| 摘要 |
A pharmaceutical formulation containing, as active ingredient, a compound of the Formula III: <IMAGE> III wherein A is a group selected from -(CH2)2-; -(CH2)3-; -(CH2)4-; -(CH2)5-; <IMAGE> wherein R is ethyl, vinyl, or cyclopropyl; and wherein X is bromo or chloro, or the pharmacologically acceptable acid addition salts for the treatment of depression in warm-blooded animals, including man.
|
